Winton Group’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.93M Buy
227,100
+181,900
+402% +$1.21M 0.06% 301
2026
Q1
$246K Buy
45,200
+11,900
+36% +$66.8K 0.01% 921
2025
Q4
$233K Buy
+33,300
New +$261K 0.01% 801
2022
Q4
– Sell
-15,200
Closed -$385K – 1033
2022
Q3
$385K Buy
+15,200
New +$533K 0.03% 713
2020
Q2
– Sell
-4,673
Closed -$724K – 1592
2020
Q1
$724K Buy
+4,673
New +$544K 0.02% 917
2019
Q2
– Sell
-4,412
Closed -$245K – 1279
2019
Q1
$245K Buy
+4,412
New +$269K ﹤0.01% 882
2018
Q4
– Sell
-4,121
Closed -$356K – 1029
2018
Q3
$356K Buy
4,121
+57
+1% +$4.06K 0.01% 743
2018
Q2
$236K Sell
4,064
-1,844
-31% -$90.1K 0.01% 913
2018
Q1
$238K Buy
+5,908
New +$223K 0.01% 1061

Other funds holding TDOC

Winton Group's TDOC Position: Q2 2026 in Review

Winton Group increased its Teladoc Health (TDOC) stake by 402% in Q2 2026, buying an estimated $1.21M and bringing the position to 227,100 shares worth $1.93M. The position accounts for 0.06% of the portfolio, ranked #301.

Winton Group first reported a position in TDOC in Q1 2018 and has held it in 9 quarters since. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Winton Group held 227,100 shares of Teladoc Health worth $1.93M as of Q2 2026.
  • Winton Group bought 181,900 Teladoc Health shares in Q2 2026, an estimated $1.21M.
  • Teladoc Health made up 0.06% of Winton Group's portfolio in Q2 2026, its #301 holding.
  • Winton Group first reported a position in Teladoc Health in Q1 2018 and has held it in 9 quarters since.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.